Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 1
2006 1
2007 5
2008 4
2009 2
2010 6
2011 3
2012 3
2013 5
2014 4
2015 2
2016 1
2017 1
2018 2
2019 3
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.
Sharad S, Sztupinszki ZM, Chen Y, Kuo C, Ravindranath L, Szallasi Z, Petrovics G, Sreenath TL, Dobi A, Rosner IL, Srinivasan A, Srivastava S, Cullen J, Li H. Sharad S, et al. Among authors: ravindranath l. Cancers (Basel). 2019 Dec 12;11(12):1995. doi: 10.3390/cancers11121995. Cancers (Basel). 2019. PMID: 31842254 Free PMC article.
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence.
Yan W, Jamal M, Tan SH, Song Y, Young D, Chen Y, Katta S, Ying K, Ravindranath L, Woodle T, Kohaar I, Cullen J, Kagan J, Srivastava S, Dobi A, McLeod DG, Rosner IL, Sesterhenn IA, Srinivasan A, Srivastava S, Petrovics G. Yan W, et al. Among authors: ravindranath l. Oncotarget. 2019 Nov 5;10(60):6466-6483. doi: 10.18632/oncotarget.27294. eCollection 2019 Nov 5. Oncotarget. 2019. PMID: 31741711 Free PMC article.
Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth.
Mohamed AA, Xavier CP, Sukumar G, Tan SH, Ravindranath L, Seraj N, Kumar V, Sreenath T, McLeod DG, Petrovics G, Rosner IL, Srivastava M, Strovel J, Malhotra SV, LaRonde NA, Dobi A, Dalgard CL, Srivastava S. Mohamed AA, et al. Among authors: ravindranath l. Cancer Res. 2018 Jul 1;78(13):3659-3671. doi: 10.1158/0008-5472.CAN-17-2949. Epub 2018 Apr 30. Cancer Res. 2018. PMID: 29712692 Free article.
In vitro microbiological evaluation of novel bis pyrazolones.
Narayana Rao DV, Raghavendra Guru Prasad A, Spoorthy YN, Raghunatha Rao D, Ravindranath LK. Narayana Rao DV, et al. Among authors: ravindranath lk. Ann Pharm Fr. 2014 Mar;72(2):101-6. doi: 10.1016/j.pharma.2013.11.005. Epub 2014 Jan 2. Ann Pharm Fr. 2014. PMID: 24630311
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.
Petrovics G, Price DK, Lou H, Chen Y, Garland L, Bass S, Jones K, Kohaar I, Ali A, Ravindranath L, Young D, Cullen J, Dorsey TH, Sesterhenn IA, Brassell SA, Rosner IL, Ross D, Dahut W, Ambs S, Figg WD, Srivastava S, Dean M. Petrovics G, et al. Among authors: ravindranath l. Prostate Cancer Prostatic Dis. 2019 Sep;22(3):406-410. doi: 10.1038/s41391-018-0114-1. Epub 2018 Dec 12. Prostate Cancer Prostatic Dis. 2019. PMID: 30542053 Free PMC article.
Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.
Mohamed AA, Tan SH, Xavier CP, Katta S, Huang W, Ravindranath L, Jamal M, Li H, Srivastava M, Srivatsan ES, Sreenath TL, McLeod DG, Srinivasan A, Petrovics G, Dobi A, Srivastava S. Mohamed AA, et al. Among authors: ravindranath l. Mol Cancer Res. 2017 Oct;15(10):1308-1317. doi: 10.1158/1541-7786.MCR-17-0058. Epub 2017 Jun 12. Mol Cancer Res. 2017. PMID: 28607007 Free PMC article.
Prostate cancer marker panel with single cell sensitivity in urine.
Nickens KP, Ali A, Scoggin T, Tan SH, Ravindranath L, McLeod DG, Dobi A, Tacha D, Sesterhenn IA, Srivastava S, Petrovics G. Nickens KP, et al. Among authors: ravindranath l. Prostate. 2015 Jun 15;75(9):969-75. doi: 10.1002/pros.22981. Epub 2015 Mar 23. Prostate. 2015. PMID: 25808739 Free PMC article.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page